Systemic effects including cognitive benefits, mood regulation, and general tissue maintenance could work with either route, though injection delivers more predictable exposure levels
Most of what's "known" comes from: Preclinical work (animal/cell) exploring repair pathways, inflammation signaling, and vascular changes Limited human observations focused more on recovery and discomfort than on body fat change So, when someone searches for BPC 157 weight loss , it's essential to set expectations: this isn't like clinically validated obesity therapies that have decades of outcome data, standardized dosing, and predictable effects on appetite and metabolic pathwayssuch as FDA-approved options like semaglutide (Wegovy) and tirzepatide (Zepbound)
As the medical journal JAMA noted, that change was not accompanied by or the result of new scientific evidence. Nothing new had been learned
Nutritional Foundation Begin transitioning to a protein-forward, moderate-calorie diet at least one to two weeks before starting therapy